Vaccine News Alert: July/Aug '25 Edition

Virginia Department of Health sent this bulletin at 06/18/2025 12:59 PM EDT

May / June 2025

Vaccine News Alert

New Virginia Immunization Information System

The new Virginia Immunization Information System (VIIS) will launch on June 24^th. VVFC providers will need to complete training to learn how to place vaccine orders and to manage their inventory. Providers have been contacted about training options and are expected to transition the Vaccine Ordering Management System (VOMS) in the coming weeks. Providers may place orders using the ordering forms or VERIP until they transition to VOMS.

CDC Revises COVID-19 Vaccine Recommendations on Schedules

On May 28, CDC posted updated versions of its recommended immunization schedules for children and adults, reflecting an update to its recommendations for use of COVID-19 vaccines in children and during pregnancy. CDC changes made in response to a recent HHS directive are as follows:

The Child and Adolescent Immunization Schedule now calls for shared clinical decision-making regarding COVID-19 vaccination for all children and adolescents aged 6 months through 17 years, including those who are moderately or severely immunocompromised. Any of these children may be vaccinated after a shared clinical decision with their healthcare provider.
Vaccines For Children (VFC)-eligible children are allowed to obtain COVID-19 vaccine at no charge through the VFC program after a shared clinical decision with their healthcare provider.
Pregnancy is now shaded gray (indicating “no guidance”) in both the Adult and Child and Adolescent Immunization Schedules by Medical Indication.
No changes were made to recommendations for COVID-19 vaccination of adults who are not pregnant and age 18 years and older.

⭐ Gold Star Awards (April/May 2025)

Outstanding VVFC Compliance

Healthy Community Health Center, Elkton

Healthy Community Health Center-Parkview, Harrisonburg

Healthy Community Health Center-Stone Port, Harrisonburg

South Main Health Center, Harrisonburg

VFC Requirements for Inventory of COVID-19 Vaccine and Nirsevimab

VFC Stock and COVID-19 Vaccine

VFC providers must stock all routine ACIP-recommended vaccines for VFC-eligible populations. Exception: COVID-19 vaccines may be excluded from a VFC provider’s VFC stock given the unique circumstance of COVID-19 vaccination.

o Providers should identify accessible locations for COVID-19 vaccination referrals.

o Enrolled providers who do not stock COVID-19 vaccines must be aware of these locations and refer eligible children accordingly.

o These procedures are like those for non-routine VFC vaccines, such as Mpox and PPSV23.

Private Stock and VFC Vaccines, including RSV Monoclonal Antibody Products

For the 2025–2026 budget period, with respect to the VFC program, if a VFC provider serves and plans to vaccinate privately insured (non-VFC-eligible) populations, they should stock a separate vaccine supply for the specific vaccines they plan to offer non-VFC-eligible patients. CDC is not requiring VFC providers to maintain a full stock of all ACIP-recommended vaccines for non-VFC-eligible patients if they do not plan to offer all ACIP-recommended vaccines to this population. This guidance includes, but is not limited to, RSV monoclonal antibody products. Example: VFC providers, including birthing hospitals, that serve both VFC-eligible and non-VFC-eligible patients indicated to receive RSV monoclonal antibody products are not required to maintain a separate stock of this product for any non-VFC-eligible patient they do not plan to vaccinate with this product. If a VFC provider does not carry private stock, they are not permitted to use VFC stock on non-VFC-eligible patients.

Note: The Addendum: Special Considerations for COVID-19 vaccine and Nirsevimab will expire on June 30, 2025.

Addendum

Adult Vaccine Update

CDC Issues Two Updated VISs for Pneumococcal Vaccines

On May 29, CDC released updated VISs for pneumococcal polysaccharide vaccine (PPSV23) and pneumococcal conjugate vaccine (PCV). Changes incorporate recommendations for the routine use of PCV for adults age 50 years and older (previously 65 years) and the limited use of PPSV23. The updated VISs refer to PCVs generally and no longer reference specific PCV products.

Virginia Vaccines for Children (VVFC) Virginia Vaccines for Adults (VVFA)

1-800-568-1929 | vvfc@vdh.virginia.gov

Manage Preferences | Unsubscribe | Subscriber Help